MTOR and prostate cancer: Notably, ChIP-sequencing studies revealed that mTOR directly engages with thousands of regulatory regions of Pol II-transcribed genes in both mouse liver and human prostate cancer cells [28,29,30], suggesting profound regulatory roles of mTOR across a plethora of transcriptional programs.